Your Health, We Care
Takeda announced the TOURMALINE-MM3 Phase 3 trial, which targets patients with multiple myeloma. Currently, Ixazomib has not been approved as a maintenance therapy for multiple myeloma.
TOURMALINE is a comprehensive clinical research and development program for Isuzomi, which includes a total of six ongoing critical trials - five are studying each major multiple myeloma patient population, and one is studying light chain amyloidosis.
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
